Long-term studies of treatments for type 2 diabetes-Reference-Cited by-同舟云学术

Long-term studies of treatments for type 2 diabetes

Published:2016-12-14 Issue:3 Volume:129 Page:352-365
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Caballero A. Enrique¹

Affiliation:

1. Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1265417

Reference69 articles.

1. International Diabetes Federation. International Diabetes Federation Atlas Sixth Edition. 2014 [cited 2016 Sep 12]. Available from: http://www.idf.org/diabetesatlas

2. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

3. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

4. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

5. Standards of Medical Care in Diabetes—2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoglycemic and hypolipidemic effects of sugar beet (Beta vulgaris L.) extract on C57BL/KsJ db/db mice;Rendiconti Lincei. Scienze Fisiche e Naturali;2022-02-17

2. In vitro cytogenetic assessment and comparison of vildagliptin and sitagliptin;Cytotechnology;2019-09-25

3. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2018-12-28

4. Beneficial effects of rutin in diabetes-induced deficits in acquisition learning, retention memory and pain perception in rats;Nutritional Neuroscience;2018-10-15

5. Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once‐daily basal insulin: A randomized, phase IV study;Diabetes, Obesity and Metabolism;2018-05